139 related articles for article (PubMed ID: 36064421)
1. The role of soluble CD80 in patients with soft tissue tumors.
Matsuyama Y; Asanuma K; Yoshida K; Hagi T; Iino T; Nakamura T; Sudo A
J Orthop Surg Res; 2022 Sep; 17(1):404. PubMed ID: 36064421
[TBL] [Abstract][Full Text] [Related]
2. Identification of a circulating soluble form of CD80: levels in patients with hematological malignancies.
Hock BD; Starling GC; Patton WN; Salm N; Bond K; McArthur LT; McKenzie JL
Leuk Lymphoma; 2004 Oct; 45(10):2111-8. PubMed ID: 15370258
[TBL] [Abstract][Full Text] [Related]
3. Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas.
Asanuma K; Nakamura T; Hayashi A; Okamoto T; Iino T; Asanuma Y; Hagi T; Kita K; Nakamura K; Sudo A
Sci Rep; 2020 Jun; 10(1):9077. PubMed ID: 32493964
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years.
Asanuma K; Nakamura T; Asanuma Y; Okamoto T; Kakimoto T; Yada Y; Hagi T; Kita K; Nakamura K; Matsumine A; Sudo A
Orthop Surg; 2020 Dec; 12(6):1726-1732. PubMed ID: 33015987
[TBL] [Abstract][Full Text] [Related]
5. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas.
Asanuma K; Nakamura T; Asanuma Y; Kakimoto T; Yada Y; Hagi T; Kita K; Matsumine A; Sudo A
Cancer Biomark; 2019; 26(2):163-170. PubMed ID: 31356193
[TBL] [Abstract][Full Text] [Related]
6. Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome.
Ozkorucu D; Cetin N; Sav NM; Yildiz B
Int Urol Nephrol; 2016 Jul; 48(7):1187-96. PubMed ID: 26922067
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of soluble costimulatory molecules as potential diagnostic biomarkers for rheumatoid arthritis using LC-MS/MS in MRM mode.
Malkawi AK; Nimer RM; Almogren M; Masood A; Alarfaj AS; Benabdelkamel H; Abdel Rahman AM; Siaj M
Clin Chim Acta; 2023 Aug; 548():117501. PubMed ID: 37516334
[TBL] [Abstract][Full Text] [Related]
8. Elevation of plasma soluble T cell costimulatory molecules CTLA-4, CD28 and CD80 in children with allergic asthma.
Ip WK; Wong CK; Leung TF; Lam CW
Int Arch Allergy Immunol; 2005 May; 137(1):45-52. PubMed ID: 15785081
[TBL] [Abstract][Full Text] [Related]
9. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.
Boudin L; de Nonneville A; Finetti P; Mescam L; Le Cesne A; Italiano A; Blay JY; Birnbaum D; Mamessier E; Bertucci F
J Transl Med; 2022 Oct; 20(1):464. PubMed ID: 36221119
[TBL] [Abstract][Full Text] [Related]
10. Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors.
Asanuma K; Nakamura T; Hagi T; Okamoto T; Kita K; Nakamura K; Matsuyama Y; Yoshida K; Asanuma Y; Sudo A
BMC Cancer; 2021 Apr; 21(1):364. PubMed ID: 33827473
[TBL] [Abstract][Full Text] [Related]
11. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
[TBL] [Abstract][Full Text] [Related]
12. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
[TBL] [Abstract][Full Text] [Related]
13. sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection.
Jubel JM; Randau TM; Becker-Gotot J; Scheidt S; Wimmer MD; Kohlhof H; Burger C; Wirtz DC; Schildberg FA
Front Immunol; 2021; 12():687065. PubMed ID: 34421900
[TBL] [Abstract][Full Text] [Related]
14. Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Pyo JY; Yoon T; Ahn SS; Song JJ; Park YB; Lee SW
Sci Rep; 2022 Dec; 12(1):21319. PubMed ID: 36494415
[TBL] [Abstract][Full Text] [Related]
15. Soluble type immune checkpoint regulators using multiplex luminex immunoassay in chronic hepatitis B patients.
Fadriquela A; Kim CS; Lee KJ; Kang SH; Kim MY; Lee JH
J Clin Pathol; 2021 Dec; 74(12):780-786. PubMed ID: 34016716
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children.
Ip WK; Wong CK; Leung TF; Lam CW
Pediatr Pulmonol; 2006 Jul; 41(7):674-82. PubMed ID: 16703581
[TBL] [Abstract][Full Text] [Related]
17. The CTLA-4 immune checkpoint protein regulates PD-L1:PD-1 interaction via transendocytosis of its ligand CD80.
Kennedy A; Robinson MA; Hinze C; Waters E; Williams C; Halliday N; Dovedi S; Sansom DM
EMBO J; 2023 Mar; 42(5):e111556. PubMed ID: 36727298
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy.
Ostrand-Rosenberg S; Horn LA; Ciavattone NG
Front Oncol; 2019; 9():215. PubMed ID: 31001479
[TBL] [Abstract][Full Text] [Related]
19. Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis.
Cao J; Zou L; Luo P; Chen P; Zhang L
Int Immunopharmacol; 2012 Dec; 14(4):585-92. PubMed ID: 22917707
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer.
Liu C; Wang P; Sun Y; Dou X; Hu X; Zou W; Sun Y; Hu Q; Yue J
Front Oncol; 2022; 12():756811. PubMed ID: 35530332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]